Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation

Table 4 Univariate Cox’s proportional hazard regression analysis of factors affecting overall survival

Parameters	P value	HR	95% CI
			Lower	Higher
DXM 40 mg vs 20 mg	0.171	0.652	0.353	1.202
Age, yr	0.000	1.178	1.121	1.238
Gender	0.602	0.846	0.451	1.587
Classification	0.14	0.211	0.027	1.665
DS stage	0.067	2.271	0.944	5.462
ISS stage	0.000	5.245	3.041	9.048
Platelet	0.417	1.010	0.987	1.033
t(6;14)	0.489	0.046	0.000	278.970
t(11;14)	0.003	0.288	0.128	0.649
CRP	0.086	1.013	0.998	1.027
HGB	0.050	0.983	0.967	1.000
ALT	0.194	1.007	0.997	1.017
AST	0.070	1.008	0.999	1.016
ALB	0.940	1.001	0.971	1.032
GLO	0.945	1.000	0.986	1.013
A/G	0.911	0.957	0.668	1.371
LDH	0.209	1.001	0.999	1.003
Ca	0.906	0.968	0.564	1.662
P	0.627	0.919	0.652	1.293
M-protein	0.652	0.998	0.992	1.005
Cr	0.623	1.000	0.999	1.001
UA	0.375	1.001	0.999	1.002
Treatment	0.173	1.375	0.869	2.174
GTA	0.546	0.694	0.212	2.271
IFG	0.030	0.263	0.078	0.881
DM	0.203	1.661	0.760	3.631
β-CTX	0.840	1.088	0.479	2.474
Osteoporosis	0.703	1.187	0.492	2.862
Hypertension	0.730	1.201	0.424	3.404
TG	0.642	0.823	0.363	1.869
TC	0.715	0.866	0.398	1.881
Acne	0.995	1.003	0.354	2.842
PU	0.686	0.808	0.286	2.277
Insomnia	0.725	1.159	0.509	2.637

CRP: Catabolite activator protein; HGB: Hemoglobin; UA: Urea nitrogen; Cr: Creatinine; LDH: Lactate dehydrogenase; GTA: Glucose tolerance; IFG: Impaired fasting glucose; DM: Diabetes mellitus; β-CTX: β-crosslaps; TC: Total cholesterol; TG: Triglyceride; PU: Peptic ulce.